BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11584067)

  • 1. Re: Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine.
    Nersesyan AK
    J Natl Cancer Inst; 2001 Oct; 93(19):1492-3. PubMed ID: 11584067
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study of occupational uroepithelial cancer].
    Hamasaki T; Aramaki K; Hida T; Inatomi H; Fujimoto N; Okamura T; Ozu K; Sugita A
    J UOEH; 1996 Dec; 18(4):247-59. PubMed ID: 8981648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine.
    Hemstreet GP; Yin S; Ma Z; Bonner RB; Bi W; Rao JY; Zang M; Zheng Q; Bane B; Asal N; Li G; Feng P; Hurst RE; Wang W
    J Natl Cancer Inst; 2001 Mar; 93(6):427-36. PubMed ID: 11259468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzidine: a bladder carcinogen.
    Wendel RG; Hoegg UR; Zavon MR
    J Urol; 1974 May; 111(5):607-10. PubMed ID: 4823968
    [No Abstract]   [Full Text] [Related]  

  • 5. [Present status and background of occupational uroepithelial tumors].
    Tachibana M; Tazaki H; Murai M; Yamaguch N
    Hinyokika Kiyo; 1989 Dec; 35(12):2003-9. PubMed ID: 2618898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the p53 gene in occupational bladder cancer in workers exposed to aromatic amines.
    Droller MJ
    J Urol; 1998 Aug; 160(2):618. PubMed ID: 9679939
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidemiology of cancer from exposure to arylamines.
    Vineis P
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):7-10. PubMed ID: 7889862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts.
    Rothman N; Hayes RB; Zenser TV; DeMarini DM; Bi W; Hirvonen A; Talaska G; Bhatnagar VK; Caporaso NE; Brooks LR; Lakshmi VM; Feng P; Kashyap SK; You X; Eischen BT; Kashyap R; Shelton ML; Hsu FF; Jaeger M; Parikh DJ; Davis BB; Yin S; Bell DA
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):979-83. PubMed ID: 8959320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to aromatic amines and ras and c-erbB-2 overexpression in bladder cancer.
    Novara R; Coda R; Martone T; Vineis P
    J Occup Environ Med; 1996 Apr; 38(4):390-3. PubMed ID: 8925323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Occupational cancer of the urinary bladder: the diagnostic value of urinary cytology in dyestuff workers exposed to aromatic amine].
    Matsushima M; Murakami N; Fukazawa K; Yagishita T; Fujio K; Miura K; Sawamura Y; Tajima M; Nakayama K; Shirai M; Ando K
    Nihon Hinyokika Gakkai Zasshi; 1983 Jan; 74(1):81-99. PubMed ID: 6865154
    [No Abstract]   [Full Text] [Related]  

  • 11. Mortality and incidence of bladder cancer in benzidine-exposed workers in China.
    Bi W; Hayes RB; Feng P; Qi Y; You X; Zhen J; Zhang M; Qu B; Fu Z; Chen M
    Am J Ind Med; 1992; 21(4):481-9. PubMed ID: 1580253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the relation between bladder cancer and benzidine or its derived dyes in Shanghai.
    You XY; Chen JG; Hu YN
    Br J Ind Med; 1990 Aug; 47(8):544-52. PubMed ID: 2393635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of the effect of improved working conditions on bladder tumor incidence in a benzidine manufacturing facility.
    Ferber KH; Hill WJ; Cobb DA
    Am Ind Hyg Assoc J; 1976 Jan; 37(1):61-8. PubMed ID: 1246951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer occurrence among dyestuff workers exposed to aromatic amines. A long term follow-up study.
    Naito S; Tanaka K; Koga H; Kotoh S; Hirohata T; Kumazawa J
    Cancer; 1995 Oct; 76(8):1445-52. PubMed ID: 8620422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of bladder cancer in a cohort of workers exposed to 4-chloro-o-toluidine while synthesising chlordimeform.
    Popp W; Schmieding W; Speck M; Vahrenholz C; Norpoth K
    Br J Ind Med; 1992 Aug; 49(8):529-31. PubMed ID: 1515344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple primary cancers involving kidney, urinary bladder, and liver in a dye worker.
    Morikawa Y; Shiomi K; Ishihara Y; Matsuura N
    Am J Ind Med; 1997 Jan; 31(1):44-9. PubMed ID: 8986253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic factors in chemically-induced transitional cell bladder cancer.
    Filiadis I; Hrouda D
    BJU Int; 2000 Nov; 86(7):794-801. PubMed ID: 11069403
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nine cases of bladder cancer occurring in occupational dye users].
    Murase T; Takashi M; Aota Y; Shimoji T; Miyake K; Mitsuya H
    Hinyokika Kiyo; 1985 Aug; 31(8):1459-62. PubMed ID: 4083208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of case-control studies in the general population and in occupational cohorts to study genetic susceptibility and cancer risk.
    Rothman N
    Med Lav; 1995; 86(3):221-5. PubMed ID: 7565281
    [No Abstract]   [Full Text] [Related]  

  • 20. Overrepresentation of the slow acetylator phenotype in painters suffering from urinary bladder cancer.
    Golka K; Kempkes M; Flieger A; Blaszkewicz M; Bolt HM
    Med Lav; 1997; 88(5):425-6. PubMed ID: 9489306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.